Aspira Pathlab & Diagnostics Ltd.
|
QUARTERLY RESULTS
|
|
You can view the
Quaterly Results
for the last 5 years.
Market Cap. (Rs.)
|
32.94 Cr.
|
P/BV
|
4.21
|
Book Value (Rs.)
|
7.60
|
52 Week High/Low (Rs.)
|
50/23
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
26/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 3.46 | 3.32 | 2.60 | 3.41 | 4.37 |
Total Income From Operations | 3.46 | 3.32 | 2.60 | 3.41 | 4.37 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 0.73 | 0.67 | 0.51 | 0.58 | 0.69 |
Employees Cost | 1.62 | 1.63 | 1.31 | 1.40 | 1.52 |
Depreciation | 0.38 | 0.39 | 0.39 | 0.38 | 0.39 |
Other Expenses | 1.49 | 1.39 | 1.11 | 1.29 | 1.34 |
Total Expenses | 4.22 | 4.08 | 3.32 | 3.64 | 3.95 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.75 | -0.76 | -0.72 | -0.24 | 0.43 |
Other Income | 0.10 | 0.14 | 0.10 | 0.07 | 0.12 |
P/L Before Interest, Excpt. Items & Tax | -0.65 | -0.61 | -0.62 | -0.16 | 0.54 |
Interest | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 |
P/L Before Exceptional Items & Tax | -0.74 | -0.71 | -0.72 | -0.26 | 0.44 |
P/L Before Tax | -0.74 | -0.71 | -0.72 | -0.26 | 0.44 |
P/L After Tax from Ordinary Activities | -0.74 | -0.71 | -0.72 | -0.26 | 0.44 |
Net Profit/Loss For the Period | -0.74 | -0.71 | -0.72 | -0.26 | 0.44 |
| | | | | |
Equity Share Capital | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | -0.72 | -0.69 | -0.70 | -0.25 | 0.43 |
Diluted EPS (Rs.) | -0.72 | -0.69 | -0.70 | -0.25 | 0.43 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | -0.72 | -0.69 | -0.70 | -0.25 | 0.43 |
Diluted EPS (Rs.) | -0.72 | -0.69 | -0.70 | -0.25 | 0.43 |
| | | | | |
PBITOE Margin (%) | -21.76 | -22.84 | -27.59 | -6.94 | 9.79 |
PBTE Margin (%) | -21.43 | -21.40 | -27.49 | -7.60 | 10.07 |
PBT Margin (%) | -21.43 | -21.40 | -27.49 | -7.60 | 10.07 |
PAT Margin (%) | -21.43 | -21.40 | -27.49 | -7.60 | 10.07 |